AZTR
AZTR clinical trials: Azitra, Inc.
Every trial on ClinicalTrials.gov where Azitra, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 4
- As lead sponsor
- 0
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
AZTR on the catalyst calendar · AZTR registry changes
| Primary completion | Trial | Company and role | Phase | Status | Enrollment | Interventions | Completion |
|---|---|---|---|---|---|---|---|
| Jul 15, 2027Sponsor estimate | NCT06830863A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal ToxicityAzitra Inc. · EGFR Inhibitor-associated Rash | AZTRLead | Phase 1/Phase 2 | Recruiting | Locked | Locked | Locked |
| Jul 7, 2026Actual | NCT06137157Evaluation of Topical ATR12-351 in Adults With Netherton SyndromeAzitra Inc. · Netherton Syndrome | AZTRLead | Phase 1 | Completed | Locked | Locked | Locked |
| Jan 2026Sponsor estimate | NCT04731259Study to Evaluate the Safety of ATR-04Azitra Inc. · Epidermal Growth Factor | AZTRLead | Phase 1/Phase 2 | Withdrawn | Locked | Locked | Locked |
| Jan 21, 2019Actual | NCT03820076Safety Study of AZT-04 for Cosmetic UseAzitra Inc. · Study of Three Doses of AZT-04 for Skin Appearance | AZTRLead | No phase registered | Completed | Locked | Locked | Locked |
- Primary completion Jul 15, 2027Sponsor estimatePhase 1/Phase 2NCT06830863A Study to Evaluate Topical ATR04-484 for EGFRi-Associated Dermal ToxicityAzitra Inc. · EGFR Inhibitor-associated RashRecruitingAZTRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 7, 2026ActualPhase 1NCT06137157Evaluation of Topical ATR12-351 in Adults With Netherton SyndromeAzitra Inc. · Netherton SyndromeCompletedAZTRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2026Sponsor estimatePhase 1/Phase 2NCT04731259Study to Evaluate the Safety of ATR-04Azitra Inc. · Epidermal Growth FactorWithdrawnAZTRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 21, 2019ActualNo phase registeredNCT03820076Safety Study of AZT-04 for Cosmetic UseAzitra Inc. · Study of Three Doses of AZT-04 for Skin AppearanceCompletedAZTRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner